Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 8/20 | 0.39 |
| ▸ | CA2 | P00918 | 8/20 | 0.39 |
| ▸ | CA9 | Q16790 | 7/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 3/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.39 |
| ▸ | CA3 | P07451 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA6 | P23280 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2330968 | 1.00 | DNM1 (0.47) | DNM1LPAR3LPAR1CA1CA2 | |
| SCHEMBL1883777 | 1.00 | DNM1 (0.47) | DNM1LPAR3LPAR1CA1CA2 | |
| SCHEMBL1411254 | 1.00 | DNM1 (0.47) | DNM1LPAR3LPAR1CA1CA2 | |
| SCHEMBL18959857 | 0.91 | CYP3A4 (0.37) | DNM1CA1CA2 | |
| SCHEMBL5163855 | 0.88 | ALDH1A1 (0.32) | DNM1 | |
| Triethylene Glycol SCHEMBL7770640 | 0.86 | MEN1 (0.61) | DNM1LPAR3LPAR1 | |
| SCHEMBL497154 | 0.82 | DNM1 (0.42) | DNM1LPAR3LPAR1CA1CA2 | |
| SCHEMBL8605070 | 0.82 | LMNA (0.39) | — | |
| SCHEMBL8542544 | 0.82 | DNM1 (0.47) | DNM1LPAR3LPAR1CA1CA2 | |
| SCHEMBL25544295 | 0.82 | DNM1 (0.47) | DNM1LPAR3LPAR1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113226032-B | Pest repellent composition | 花王株式会社 | 2023-01-03 | — | — | CN | claimed |
| CN-113226031-B | Pest repellent composition | 花王株式会社 | 2022-11-29 | — | — | CN | claimed |
| US-9943709-B2 | Skin cleansing composition | KAO CORPORATION (JP) | 2018-04-17 | — | — | US | claimed |
| EP-2589693-B1 | NANOFIBER | KAO CORP (JP) | 2017-10-04 | — | — | EP | claimed |
| US-20160101036-A1 | SKIN CLEANSING COMPOSITION | KAO CORPORATION (JP) | 2016-04-14 | — | — | US | claimed |
| US-9180085-B2 | Inverse latices based on fatty alcohol ethers, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2015-11-10 | — | — | US | claimed |
| EP-2293771-B1 | NOVEL INVERSE LATICES THAT ARE FREE OF OXYETHYLENE DERIVATIVES, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | SOCIÉTÉ D EXPL DE PRODUITS POUR LES IND CHIMIQUES SEPPIC (FR) | 2014-12-03 | — | — | EP | claimed |
| EP-2293770-B1 | NOVEL INVERSE LATICES BASED ON FATTY ALCOHOL ETHERS, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | SOCIÉTÉ D EXPL DE PRODUITS POUR LES IND CHIMIQUES SEPPIC (FR) | 2014-08-06 | — | — | EP | claimed |
| US-20130125912-A1 | NANOFIBER | KAO CORPORATION (JP) | 2013-05-23 | — | — | US | claimed |
| CN-102076324-B | Novel inverse latices that are free of oxyethylene derivatives, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same | SEPPIC SA | 2013-04-17 | — | — | CN | claimed |
| CN-102076323-B | Novel inverse latices based on fatty alcohol ethers, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compositions comprising same | SEPPIC SA | 2013-04-17 | — | — | CN | claimed |
| US-20110098364-A1 | NOVEL INVERSE LATICES BASED ON FATTY ALCOHOL ETHERS, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2011-04-28 | — | — | US | claimed |
| US-20110076245-A1 | NOVEL INVERSE LATICES THAT ARE FREE OF OXYETHYLENE DERIVATIVES, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | Societe D"exploitation De Produits Pour Les Industries Chimiques Seppic (FR) | 2011-03-31 | — | — | US | claimed |
| EP-2293770-A2 | NOVEL INVERSE LATICES BASED ON FATTY ALCOHOL ETHERS, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2011-03-16 | — | — | EP | claimed |
| EP-2293771-A2 | NOVEL INVERSE LATICES THAT ARE FREE OF OXYETHYLENE DERIVATIVES, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2011-03-16 | — | — | EP | claimed |
| WO-2009156691-A2 | NOVEL INVERSE LATICES THAT ARE FREE OF OXYETHYLENE DERIVATIVES, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2009-12-30 | — | — | WO | claimed |
| WO-2009156690-A2 | NOVEL INVERSE LATICES BASED ON FATTY ALCOHOL ETHERS, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2009-12-30 | — | — | WO | claimed |
| US-20260144731-A1 | AQUEOUS GEL, COSMETIC USE THEREOF AND PROCESS FOR REDUCING THE TACKINESS FELT DURING ITS APPLICATION | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2026-05-28 | — | — | US | disclosed |
| EP-0753500-A2 | Process for producing ether compound | KAO CORPORATION (JP) | 1997-01-15 | — | — | EP | disclosed |
| WO-1996036583-A1 | NOVEL ETHER COMPOUND AND PROCESS FOR PRODUCING THE SAME | KAO CORPORATION (JP) | 1996-11-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144731-A1 | AQUEOUS GEL, COSMETIC USE THEREOF AND PROCESS FOR REDUCING THE TACKINESS FELT DURING ITS APPLICATION | OGG1, CUTA, ACP1 | DNM1 4022/4885LPAR3 712/4885LPAR1 455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.